Precision Business Insights


Renal Biomarkers Market

: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global Renal Biomarkers Market By Biomarker Type (Functional Biomarkers, Up-Regulated Proteins, Others ), By Diagnostic Technique (Particle enhanced turbidimetric immunoassay, Chemiluminescent enzyme immunoassay, Enzyme linked immunosorbent assay, Colorimetric assay, Liquid chromatography), By End User (Hospitals, Outpatient Clinics, Research Centers, Diagnostic Labs), and Geography 


Renal Biomarkers Market Outline

Renal diseases are one of the major cause of death in geriatric population. Renal biomarkers are measurable indicators used to screening, monitoring, and diagnosing the activity of renal diseases by determining their blood and urine levels. The biomarkers are administered into kidneys to determine the renal functions. The early diagnosis of renal diseases helps to take proper treatment before the irreversible damage of kidneys.


Market Dynamics: Renal Biomarkers Market

Increase in the prevalence of renal diseases due to rise in hypertension and diabetes in elderly patients is a major factor fuel the renal biomarkers market. Rise in geriatric population, increase in the R&D for the development of novel renal biomarkers, and using of renal biomarkers in preclinical and clinical trials to determine the safety of new drugs are anticipated to propel the market. However, stringent regulatory scenario, lack of specificity and sensitivity in current renal biomarkers, and lack of favorable reimbursement policies are anticipated to impede the growth of renal biomarkers market.


Market Scope: Renal Biomarkers Market

Renal biomarkers market is segmented based on the biomarker type, diagnostic technique, and end user


Based on the biomarker type, the market is segmented into the following:

  • Functional Biomarkers
    • Serum Cystatin C
    • Serum Creatinine
    • Urine Albumin
  • Up-Regulated Proteins
    • Kidney Injury Molecule 1
    • Nutrophil gelatinase associated lipocalin
    • Interleukin 18
  • Others


Based on the diagnostic technique, the market is segmented into the following:

  • Particle enhanced turbidimetric immunoassay
  • Chemiluminescent enzyme immunoassay
  • Enzyme linked immunosorbent assay
  • Colorimetric assay
  • Liquid chromatography


Based on the end user, the market is segmented into the following:

  • Hospitals
  • Outpatient Clinics
  • Research Centers
  • Diagnostic Labs


Regional Analysis:


North America

  • US
  • Canada


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe


  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA


North America renal biomarkers market is expected to expand at significant CAGR due to its raising ageing population along with increased prevalence of renal disorders. The state-of-art healthcare infrastructure, and favorable reimbursement policies are expected to enhance the growth of renal biomarkers market. The existence of the manufacturers in large number, surge in R&D investments are expected to fuel the growth of market. The well established distribution channels further enhance the growth of the market. Europe market is anticipated to offer enormous opportunities for the market players plunged in market. Asia Pacific  market is led by China, Japan, and India due to increasing geriatric population coupled with increased prevalence of renal disorders.


Competition Assessment: Renal Biomarkers Market

  • Merck Millipore (U.S)
  • Thermo Fisher Scientific Inc (U.S)
  • Hoffmann-La Roche Ag (Switzerland)
  • Abbott Molecular Inc (U.S)
  • Beckman Coulter Inc (U.S)
  • Astute Medical Inc (U.S)
  • Randox Laboratories Ltd (Ireland)


Notable Market Developments

  • In December 2017, Thermo Fisher Scientific Completes Acquisition of Phenom-World.


Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Merck Millipore (U.S)
  • Thermo Fisher Scientific Inc (U.S)
  • Hoffmann-La Roche Ag (Switzerland)
  • Abbott Molecular Inc (U.S)
  • Beckman Coulter Inc (U.S)
  • Astute Medical Inc (U.S)
  • Randox Laboratories Ltd (Ireland)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements


$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
Single User $ 4,400.00
Multiple User $ 6,600.00
Corporate User $ 8,900.00
buy now spinner

Our Clients